Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
HS-10380
DRUG
3 trials
Sponsors
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions
SCHIZOPHRENIA 1 (Disorder)
Schizophrenia
Phase 1
A Study of HS-10380 in Chinese Participants
NCT05480592
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Schizophrenia
Start: 2022-08-01
End: 2023-07-30
Target: 76
Updated: 2023-03-09
Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia
NCT05964790
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Schizophrenia
Start: 2023-07-30
End: 2024-12-30
Target: 112
Updated: 2023-07-28
Phase 3
A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
Not yet recruiting
NCT07759869
Jiangsu Hansoh Pharmaceutical Co., Ltd.
SCHIZOPHRENIA 1 (Disorder)
Start: 2026-09-09
End: 2028-08-31
Target: 500
Updated: 2026-08-12